nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—OPRM1—nerve—multiple sclerosis	0.0063	0.215	CbGeAlD
Remifentanil—OPRM1—brainstem—multiple sclerosis	0.0027	0.0925	CbGeAlD
Remifentanil—OPRD1—nervous system—multiple sclerosis	0.00208	0.0711	CbGeAlD
Remifentanil—OPRD1—central nervous system—multiple sclerosis	0.002	0.0684	CbGeAlD
Remifentanil—OPRK1—nervous system—multiple sclerosis	0.00199	0.0681	CbGeAlD
Remifentanil—OPRK1—central nervous system—multiple sclerosis	0.00192	0.0656	CbGeAlD
Remifentanil—OPRK1—cerebellum—multiple sclerosis	0.00187	0.0641	CbGeAlD
Remifentanil—Alfentanil—ALB—multiple sclerosis	0.00177	0.689	CrCbGaD
Remifentanil—OPRM1—midbrain—multiple sclerosis	0.00172	0.0589	CbGeAlD
Remifentanil—OPRM1—spinal cord—multiple sclerosis	0.00168	0.0575	CbGeAlD
Remifentanil—OPRD1—brain—multiple sclerosis	0.00159	0.0543	CbGeAlD
Remifentanil—OPRK1—brain—multiple sclerosis	0.00152	0.0521	CbGeAlD
Remifentanil—OPRM1—nervous system—multiple sclerosis	0.00142	0.0485	CbGeAlD
Remifentanil—OPRM1—central nervous system—multiple sclerosis	0.00136	0.0467	CbGeAlD
Remifentanil—OPRM1—brain—multiple sclerosis	0.00108	0.037	CbGeAlD
Remifentanil—Arrhythmia—Methylprednisolone—multiple sclerosis	0.00108	0.00155	CcSEcCtD
Remifentanil—Hyperglycaemia—Prednisone—multiple sclerosis	0.00108	0.00155	CcSEcCtD
Remifentanil—Hypotension—Mitoxantrone—multiple sclerosis	0.00106	0.00153	CcSEcCtD
Remifentanil—Visual impairment—Dexamethasone—multiple sclerosis	0.00106	0.00152	CcSEcCtD
Remifentanil—Visual impairment—Betamethasone—multiple sclerosis	0.00106	0.00152	CcSEcCtD
Remifentanil—Erythema—Triamcinolone—multiple sclerosis	0.00105	0.00152	CcSEcCtD
Remifentanil—Erythema—Methylprednisolone—multiple sclerosis	0.00105	0.00151	CcSEcCtD
Remifentanil—Hypersensitivity—Azathioprine—multiple sclerosis	0.00104	0.00149	CcSEcCtD
Remifentanil—Nausea—Cladribine—multiple sclerosis	0.00103	0.00148	CcSEcCtD
Remifentanil—Syncope—Prednisolone—multiple sclerosis	0.00102	0.00148	CcSEcCtD
Remifentanil—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00102	0.00147	CcSEcCtD
Remifentanil—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00101	0.00146	CcSEcCtD
Remifentanil—Somnolence—Mitoxantrone—multiple sclerosis	0.00101	0.00146	CcSEcCtD
Remifentanil—Loss of consciousness—Prednisolone—multiple sclerosis	0.001	0.00145	CcSEcCtD
Remifentanil—Dyspepsia—Mitoxantrone—multiple sclerosis	0.001	0.00144	CcSEcCtD
Remifentanil—Angiopathy—Betamethasone—multiple sclerosis	0.000994	0.00143	CcSEcCtD
Remifentanil—Angiopathy—Dexamethasone—multiple sclerosis	0.000994	0.00143	CcSEcCtD
Remifentanil—Convulsion—Prednisolone—multiple sclerosis	0.00099	0.00143	CcSEcCtD
Remifentanil—Hypertension—Prednisolone—multiple sclerosis	0.000987	0.00142	CcSEcCtD
Remifentanil—Arrhythmia—Betamethasone—multiple sclerosis	0.000979	0.00141	CcSEcCtD
Remifentanil—Arrhythmia—Dexamethasone—multiple sclerosis	0.000979	0.00141	CcSEcCtD
Remifentanil—Constipation—Mitoxantrone—multiple sclerosis	0.000972	0.0014	CcSEcCtD
Remifentanil—Pain—Mitoxantrone—multiple sclerosis	0.000972	0.0014	CcSEcCtD
Remifentanil—Bradycardia—Prednisone—multiple sclerosis	0.000971	0.0014	CcSEcCtD
Remifentanil—Diarrhoea—Azathioprine—multiple sclerosis	0.000962	0.00139	CcSEcCtD
Remifentanil—Haemoglobin—Prednisone—multiple sclerosis	0.000959	0.00138	CcSEcCtD
Remifentanil—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000955	0.00138	CcSEcCtD
Remifentanil—Haemorrhage—Prednisone—multiple sclerosis	0.000954	0.00138	CcSEcCtD
Remifentanil—Erythema—Betamethasone—multiple sclerosis	0.000954	0.00138	CcSEcCtD
Remifentanil—Erythema—Dexamethasone—multiple sclerosis	0.000954	0.00138	CcSEcCtD
Remifentanil—Hallucination—Prednisone—multiple sclerosis	0.000949	0.00137	CcSEcCtD
Remifentanil—Syncope—Triamcinolone—multiple sclerosis	0.000942	0.00136	CcSEcCtD
Remifentanil—Syncope—Methylprednisolone—multiple sclerosis	0.00094	0.00136	CcSEcCtD
Remifentanil—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000937	0.00135	CcSEcCtD
Remifentanil—Oedema—Prednisolone—multiple sclerosis	0.000933	0.00135	CcSEcCtD
Remifentanil—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000933	0.00135	CcSEcCtD
Remifentanil—Dysuria—Methotrexate—multiple sclerosis	0.000931	0.00134	CcSEcCtD
Remifentanil—Dizziness—Azathioprine—multiple sclerosis	0.00093	0.00134	CcSEcCtD
Remifentanil—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000924	0.00133	CcSEcCtD
Remifentanil—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000922	0.00133	CcSEcCtD
Remifentanil—Shock—Prednisolone—multiple sclerosis	0.000918	0.00132	CcSEcCtD
Remifentanil—Cough—Triamcinolone—multiple sclerosis	0.000917	0.00132	CcSEcCtD
Remifentanil—Convulsion—Triamcinolone—multiple sclerosis	0.000911	0.00131	CcSEcCtD
Remifentanil—Tachycardia—Prednisolone—multiple sclerosis	0.00091	0.00131	CcSEcCtD
Remifentanil—Convulsion—Methylprednisolone—multiple sclerosis	0.000909	0.00131	CcSEcCtD
Remifentanil—Hypertension—Triamcinolone—multiple sclerosis	0.000907	0.00131	CcSEcCtD
Remifentanil—Hypertension—Methylprednisolone—multiple sclerosis	0.000905	0.00131	CcSEcCtD
Remifentanil—Urticaria—Mitoxantrone—multiple sclerosis	0.000903	0.0013	CcSEcCtD
Remifentanil—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000902	0.0013	CcSEcCtD
Remifentanil—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000899	0.0013	CcSEcCtD
Remifentanil—Vomiting—Azathioprine—multiple sclerosis	0.000894	0.00129	CcSEcCtD
Remifentanil—Pneumonia—Methotrexate—multiple sclerosis	0.000893	0.00129	CcSEcCtD
Remifentanil—Anxiety—Methylprednisolone—multiple sclerosis	0.00089	0.00128	CcSEcCtD
Remifentanil—Rash—Azathioprine—multiple sclerosis	0.000887	0.00128	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000887	0.00128	CcSEcCtD
Remifentanil—Dermatitis—Azathioprine—multiple sclerosis	0.000886	0.00128	CcSEcCtD
Remifentanil—Flushing—Prednisone—multiple sclerosis	0.000885	0.00128	CcSEcCtD
Remifentanil—Headache—Azathioprine—multiple sclerosis	0.000881	0.00127	CcSEcCtD
Remifentanil—Dry mouth—Triamcinolone—multiple sclerosis	0.000875	0.00126	CcSEcCtD
Remifentanil—Renal failure—Methotrexate—multiple sclerosis	0.000873	0.00126	CcSEcCtD
Remifentanil—Angiopathy—Prednisone—multiple sclerosis	0.000866	0.00125	CcSEcCtD
Remifentanil—Confusional state—Methylprednisolone—multiple sclerosis	0.000863	0.00124	CcSEcCtD
Remifentanil—Immune system disorder—Prednisone—multiple sclerosis	0.000862	0.00124	CcSEcCtD
Remifentanil—Oedema—Triamcinolone—multiple sclerosis	0.000858	0.00124	CcSEcCtD
Remifentanil—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000858	0.00124	CcSEcCtD
Remifentanil—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000856	0.00123	CcSEcCtD
Remifentanil—Syncope—Betamethasone—multiple sclerosis	0.000855	0.00123	CcSEcCtD
Remifentanil—Syncope—Dexamethasone—multiple sclerosis	0.000855	0.00123	CcSEcCtD
Remifentanil—Arrhythmia—Prednisone—multiple sclerosis	0.000852	0.00123	CcSEcCtD
Remifentanil—Sweating—Methotrexate—multiple sclerosis	0.000851	0.00123	CcSEcCtD
Remifentanil—Haematuria—Methotrexate—multiple sclerosis	0.000847	0.00122	CcSEcCtD
Remifentanil—Shock—Triamcinolone—multiple sclerosis	0.000844	0.00122	CcSEcCtD
Remifentanil—Shock—Methylprednisolone—multiple sclerosis	0.000842	0.00121	CcSEcCtD
Remifentanil—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000839	0.00121	CcSEcCtD
Remifentanil—Loss of consciousness—Betamethasone—multiple sclerosis	0.000838	0.00121	CcSEcCtD
Remifentanil—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000838	0.00121	CcSEcCtD
Remifentanil—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000838	0.00121	CcSEcCtD
Remifentanil—Paraesthesia—Prednisolone—multiple sclerosis	0.000838	0.00121	CcSEcCtD
Remifentanil—Tachycardia—Triamcinolone—multiple sclerosis	0.000837	0.00121	CcSEcCtD
Remifentanil—Nausea—Azathioprine—multiple sclerosis	0.000835	0.0012	CcSEcCtD
Remifentanil—Tachycardia—Methylprednisolone—multiple sclerosis	0.000835	0.0012	CcSEcCtD
Remifentanil—Skin disorder—Methylprednisolone—multiple sclerosis	0.000831	0.0012	CcSEcCtD
Remifentanil—Erythema—Prednisone—multiple sclerosis	0.00083	0.0012	CcSEcCtD
Remifentanil—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000829	0.0012	CcSEcCtD
Remifentanil—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000827	0.00119	CcSEcCtD
Remifentanil—Convulsion—Betamethasone—multiple sclerosis	0.000826	0.00119	CcSEcCtD
Remifentanil—Convulsion—Dexamethasone—multiple sclerosis	0.000826	0.00119	CcSEcCtD
Remifentanil—Hypertension—Dexamethasone—multiple sclerosis	0.000823	0.00119	CcSEcCtD
Remifentanil—Hypertension—Betamethasone—multiple sclerosis	0.000823	0.00119	CcSEcCtD
Remifentanil—Anxiety—Betamethasone—multiple sclerosis	0.000809	0.00117	CcSEcCtD
Remifentanil—Anxiety—Dexamethasone—multiple sclerosis	0.000809	0.00117	CcSEcCtD
Remifentanil—Haemoglobin—Methotrexate—multiple sclerosis	0.000801	0.00116	CcSEcCtD
Remifentanil—Hypotension—Methylprednisolone—multiple sclerosis	0.0008	0.00115	CcSEcCtD
Remifentanil—Pethidine—ALB—multiple sclerosis	0.000798	0.311	CrCbGaD
Remifentanil—Pain—Prednisolone—multiple sclerosis	0.000798	0.00115	CcSEcCtD
Remifentanil—Haemorrhage—Methotrexate—multiple sclerosis	0.000797	0.00115	CcSEcCtD
Remifentanil—Pharyngitis—Methotrexate—multiple sclerosis	0.000791	0.00114	CcSEcCtD
Remifentanil—Oedema—Betamethasone—multiple sclerosis	0.000778	0.00112	CcSEcCtD
Remifentanil—Oedema—Dexamethasone—multiple sclerosis	0.000778	0.00112	CcSEcCtD
Remifentanil—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000778	0.00112	CcSEcCtD
Remifentanil—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000778	0.00112	CcSEcCtD
Remifentanil—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000778	0.00112	CcSEcCtD
Remifentanil—Paraesthesia—Triamcinolone—multiple sclerosis	0.00077	0.00111	CcSEcCtD
Remifentanil—Feeling abnormal—Prednisolone—multiple sclerosis	0.000769	0.00111	CcSEcCtD
Remifentanil—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000768	0.00111	CcSEcCtD
Remifentanil—Visual impairment—Methotrexate—multiple sclerosis	0.000768	0.00111	CcSEcCtD
Remifentanil—Anaemia—Prednisone—multiple sclerosis	0.000768	0.00111	CcSEcCtD
Remifentanil—Shock—Dexamethasone—multiple sclerosis	0.000766	0.0011	CcSEcCtD
Remifentanil—Shock—Betamethasone—multiple sclerosis	0.000766	0.0011	CcSEcCtD
Remifentanil—Dyspnoea—Triamcinolone—multiple sclerosis	0.000765	0.0011	CcSEcCtD
Remifentanil—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000763	0.0011	CcSEcCtD
Remifentanil—Nervous system disorder—Betamethasone—multiple sclerosis	0.000763	0.0011	CcSEcCtD
Remifentanil—Agitation—Prednisone—multiple sclerosis	0.000763	0.0011	CcSEcCtD
Remifentanil—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000762	0.0011	CcSEcCtD
Remifentanil—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000762	0.0011	CcSEcCtD
Remifentanil—Tachycardia—Dexamethasone—multiple sclerosis	0.00076	0.0011	CcSEcCtD
Remifentanil—Tachycardia—Betamethasone—multiple sclerosis	0.00076	0.0011	CcSEcCtD
Remifentanil—Dyspepsia—Triamcinolone—multiple sclerosis	0.000755	0.00109	CcSEcCtD
Remifentanil—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000753	0.00109	CcSEcCtD
Remifentanil—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000752	0.00109	CcSEcCtD
Remifentanil—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000752	0.00109	CcSEcCtD
Remifentanil—Syncope—Prednisone—multiple sclerosis	0.000745	0.00107	CcSEcCtD
Remifentanil—Urticaria—Prednisolone—multiple sclerosis	0.000741	0.00107	CcSEcCtD
Remifentanil—Cardiac disorder—Methotrexate—multiple sclerosis	0.00074	0.00107	CcSEcCtD
Remifentanil—Pain—Triamcinolone—multiple sclerosis	0.000733	0.00106	CcSEcCtD
Remifentanil—Loss of consciousness—Prednisone—multiple sclerosis	0.00073	0.00105	CcSEcCtD
Remifentanil—Hypotension—Dexamethasone—multiple sclerosis	0.000727	0.00105	CcSEcCtD
Remifentanil—Hypotension—Betamethasone—multiple sclerosis	0.000727	0.00105	CcSEcCtD
Remifentanil—Angiopathy—Methotrexate—multiple sclerosis	0.000723	0.00104	CcSEcCtD
Remifentanil—Vomiting—Mitoxantrone—multiple sclerosis	0.000723	0.00104	CcSEcCtD
Remifentanil—Immune system disorder—Methotrexate—multiple sclerosis	0.00072	0.00104	CcSEcCtD
Remifentanil—Convulsion—Prednisone—multiple sclerosis	0.00072	0.00104	CcSEcCtD
Remifentanil—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000719	0.00104	CcSEcCtD
Remifentanil—Hypertension—Prednisone—multiple sclerosis	0.000717	0.00103	CcSEcCtD
Remifentanil—Rash—Mitoxantrone—multiple sclerosis	0.000717	0.00103	CcSEcCtD
Remifentanil—Dermatitis—Mitoxantrone—multiple sclerosis	0.000716	0.00103	CcSEcCtD
Remifentanil—Chills—Methotrexate—multiple sclerosis	0.000715	0.00103	CcSEcCtD
Remifentanil—Headache—Mitoxantrone—multiple sclerosis	0.000712	0.00103	CcSEcCtD
Remifentanil—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000707	0.00102	CcSEcCtD
Remifentanil—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000705	0.00102	CcSEcCtD
Remifentanil—Anxiety—Prednisone—multiple sclerosis	0.000705	0.00102	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000702	0.00101	CcSEcCtD
Remifentanil—Paraesthesia—Betamethasone—multiple sclerosis	0.000699	0.00101	CcSEcCtD
Remifentanil—Paraesthesia—Dexamethasone—multiple sclerosis	0.000699	0.00101	CcSEcCtD
Remifentanil—Erythema—Methotrexate—multiple sclerosis	0.000694	0.001	CcSEcCtD
Remifentanil—Hypersensitivity—Prednisolone—multiple sclerosis	0.000687	0.000991	CcSEcCtD
Remifentanil—Dyspepsia—Dexamethasone—multiple sclerosis	0.000685	0.000988	CcSEcCtD
Remifentanil—Dyspepsia—Betamethasone—multiple sclerosis	0.000685	0.000988	CcSEcCtD
Remifentanil—Urticaria—Triamcinolone—multiple sclerosis	0.000681	0.000983	CcSEcCtD
Remifentanil—Urticaria—Methylprednisolone—multiple sclerosis	0.00068	0.000981	CcSEcCtD
Remifentanil—Body temperature increased—Triamcinolone—multiple sclerosis	0.000678	0.000978	CcSEcCtD
Remifentanil—Anaphylactic shock—Prednisone—multiple sclerosis	0.000678	0.000978	CcSEcCtD
Remifentanil—Oedema—Prednisone—multiple sclerosis	0.000678	0.000978	CcSEcCtD
Remifentanil—Nausea—Mitoxantrone—multiple sclerosis	0.000675	0.000974	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000672	0.000969	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000672	0.000969	CcSEcCtD
Remifentanil—Shock—Prednisone—multiple sclerosis	0.000667	0.000962	CcSEcCtD
Remifentanil—Pain—Dexamethasone—multiple sclerosis	0.000666	0.00096	CcSEcCtD
Remifentanil—Pain—Betamethasone—multiple sclerosis	0.000666	0.00096	CcSEcCtD
Remifentanil—Nervous system disorder—Prednisone—multiple sclerosis	0.000665	0.000959	CcSEcCtD
Remifentanil—Tachycardia—Prednisone—multiple sclerosis	0.000661	0.000954	CcSEcCtD
Remifentanil—Skin disorder—Prednisone—multiple sclerosis	0.000658	0.000949	CcSEcCtD
Remifentanil—Hyperhidrosis—Prednisone—multiple sclerosis	0.000655	0.000945	CcSEcCtD
Remifentanil—Anaemia—Methotrexate—multiple sclerosis	0.000641	0.000925	CcSEcCtD
Remifentanil—Feeling abnormal—Betamethasone—multiple sclerosis	0.000641	0.000925	CcSEcCtD
Remifentanil—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000641	0.000925	CcSEcCtD
Remifentanil—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000632	0.000911	CcSEcCtD
Remifentanil—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000631	0.000909	CcSEcCtD
Remifentanil—OPRD1—GPCR ligand binding—CNR1—multiple sclerosis	0.000628	0.00228	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—RGS1—multiple sclerosis	0.000625	0.00227	CbGpPWpGaD
Remifentanil—Urticaria—Betamethasone—multiple sclerosis	0.000618	0.000892	CcSEcCtD
Remifentanil—Urticaria—Dexamethasone—multiple sclerosis	0.000618	0.000892	CcSEcCtD
Remifentanil—Dizziness—Prednisolone—multiple sclerosis	0.000617	0.00089	CcSEcCtD
Remifentanil—Body temperature increased—Dexamethasone—multiple sclerosis	0.000615	0.000887	CcSEcCtD
Remifentanil—Body temperature increased—Betamethasone—multiple sclerosis	0.000615	0.000887	CcSEcCtD
Remifentanil—OPRK1—GPCR ligand binding—CXCR3—multiple sclerosis	0.000613	0.00223	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000611	0.00222	CbGpPWpGaD
Remifentanil—Paraesthesia—Prednisone—multiple sclerosis	0.000609	0.000878	CcSEcCtD
Remifentanil—Pruritus—Triamcinolone—multiple sclerosis	0.000607	0.000875	CcSEcCtD
Remifentanil—Cough—Methotrexate—multiple sclerosis	0.000606	0.000873	CcSEcCtD
Remifentanil—Pruritus—Methylprednisolone—multiple sclerosis	0.000605	0.000873	CcSEcCtD
Remifentanil—OPRK1—GPCR downstream signaling—RGS1—multiple sclerosis	0.000603	0.00219	CbGpPWpGaD
Remifentanil—Convulsion—Methotrexate—multiple sclerosis	0.000601	0.000867	CcSEcCtD
Remifentanil—OPRM1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.0006	0.00218	CbGpPWpGaD
Remifentanil—Dyspepsia—Prednisone—multiple sclerosis	0.000597	0.00086	CcSEcCtD
Remifentanil—OPRD1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000597	0.00217	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000597	0.00217	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CCR2—multiple sclerosis	0.000596	0.00217	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—CCL5—multiple sclerosis	0.000595	0.00217	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—GPR65—multiple sclerosis	0.000592	0.00215	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000589	0.00214	CbGpPWpGaD
Remifentanil—OPRK1—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.000588	0.00214	CbGpPWpGaD
Remifentanil—Rash—Prednisolone—multiple sclerosis	0.000588	0.000848	CcSEcCtD
Remifentanil—Dermatitis—Prednisolone—multiple sclerosis	0.000588	0.000847	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000587	0.000846	CcSEcCtD
Remifentanil—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000586	0.000845	CcSEcCtD
Remifentanil—Headache—Prednisolone—multiple sclerosis	0.000584	0.000843	CcSEcCtD
Remifentanil—Constipation—Prednisone—multiple sclerosis	0.00058	0.000836	CcSEcCtD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000576	0.00209	CbGpPWpGaD
Remifentanil—OPRK1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.000575	0.00209	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—LINGO1—multiple sclerosis	0.000573	0.00208	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—GPR65—multiple sclerosis	0.000572	0.00208	CbGpPWpGaD
Remifentanil—Confusional state—Methotrexate—multiple sclerosis	0.000571	0.000824	CcSEcCtD
Remifentanil—Dizziness—Triamcinolone—multiple sclerosis	0.000567	0.000818	CcSEcCtD
Remifentanil—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000566	0.000817	CcSEcCtD
Remifentanil—Dizziness—Methylprednisolone—multiple sclerosis	0.000566	0.000816	CcSEcCtD
Remifentanil—OPRD1—G alpha (i) signalling events—POMC—multiple sclerosis	0.000566	0.00206	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000565	0.00206	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00056	0.00204	CbGpPWpGaD
Remifentanil—Feeling abnormal—Prednisone—multiple sclerosis	0.000559	0.000806	CcSEcCtD
Remifentanil—OPRM1—GPCR ligand binding—CCL3—multiple sclerosis	0.000557	0.00203	CbGpPWpGaD
Remifentanil—OPRM1—Opioid Signalling—MAPK1—multiple sclerosis	0.000556	0.00202	CbGpPWpGaD
Remifentanil—Nervous system disorder—Methotrexate—multiple sclerosis	0.000555	0.000801	CcSEcCtD
Remifentanil—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000555	0.0008	CcSEcCtD
Remifentanil—Nausea—Prednisolone—multiple sclerosis	0.000554	0.000799	CcSEcCtD
Remifentanil—Pruritus—Dexamethasone—multiple sclerosis	0.000551	0.000794	CcSEcCtD
Remifentanil—Pruritus—Betamethasone—multiple sclerosis	0.000551	0.000794	CcSEcCtD
Remifentanil—OPRK1—GPCR ligand binding—CNR1—multiple sclerosis	0.00055	0.002	CbGpPWpGaD
Remifentanil—Skin disorder—Methotrexate—multiple sclerosis	0.00055	0.000794	CcSEcCtD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00055	0.002	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—RGS1—multiple sclerosis	0.000548	0.00199	CbGpPWpGaD
Remifentanil—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000548	0.00079	CcSEcCtD
Remifentanil—Vomiting—Triamcinolone—multiple sclerosis	0.000545	0.000787	CcSEcCtD
Remifentanil—OPRM1—Signaling by GPCR—S1PR1—multiple sclerosis	0.000545	0.00198	CbGpPWpGaD
Remifentanil—Vomiting—Methylprednisolone—multiple sclerosis	0.000544	0.000785	CcSEcCtD
Remifentanil—OPRD1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000542	0.00197	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCR1—multiple sclerosis	0.000542	0.00197	CbGpPWpGaD
Remifentanil—Rash—Triamcinolone—multiple sclerosis	0.000541	0.00078	CcSEcCtD
Remifentanil—Dermatitis—Triamcinolone—multiple sclerosis	0.00054	0.000779	CcSEcCtD
Remifentanil—Rash—Methylprednisolone—multiple sclerosis	0.00054	0.000778	CcSEcCtD
Remifentanil—Dermatitis—Methylprednisolone—multiple sclerosis	0.000539	0.000778	CcSEcCtD
Remifentanil—Urticaria—Prednisone—multiple sclerosis	0.000538	0.000777	CcSEcCtD
Remifentanil—Headache—Triamcinolone—multiple sclerosis	0.000537	0.000775	CcSEcCtD
Remifentanil—OPRM1—GPCR ligand binding—PTGER4—multiple sclerosis	0.000537	0.00195	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—CCR5—multiple sclerosis	0.000536	0.00195	CbGpPWpGaD
Remifentanil—Headache—Methylprednisolone—multiple sclerosis	0.000536	0.000773	CcSEcCtD
Remifentanil—Body temperature increased—Prednisone—multiple sclerosis	0.000536	0.000773	CcSEcCtD
Remifentanil—Diarrhoea—Betamethasone—multiple sclerosis	0.000532	0.000768	CcSEcCtD
Remifentanil—Diarrhoea—Dexamethasone—multiple sclerosis	0.000532	0.000768	CcSEcCtD
Remifentanil—Hypotension—Methotrexate—multiple sclerosis	0.000529	0.000763	CcSEcCtD
Remifentanil—OPRK1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000523	0.0019	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000523	0.0019	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—TGFB1—multiple sclerosis	0.000521	0.0019	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—GPR65—multiple sclerosis	0.000519	0.00189	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CXCR3—multiple sclerosis	0.000518	0.00189	CbGpPWpGaD
Remifentanil—Dizziness—Betamethasone—multiple sclerosis	0.000515	0.000742	CcSEcCtD
Remifentanil—Dizziness—Dexamethasone—multiple sclerosis	0.000515	0.000742	CcSEcCtD
Remifentanil—OPRM1—TCR Signaling Pathway—MAPK1—multiple sclerosis	0.000511	0.00186	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—RGS1—multiple sclerosis	0.00051	0.00186	CbGpPWpGaD
Remifentanil—Nausea—Triamcinolone—multiple sclerosis	0.000509	0.000735	CcSEcCtD
Remifentanil—Paraesthesia—Methotrexate—multiple sclerosis	0.000509	0.000734	CcSEcCtD
Remifentanil—Nausea—Methylprednisolone—multiple sclerosis	0.000508	0.000733	CcSEcCtD
Remifentanil—Dyspnoea—Methotrexate—multiple sclerosis	0.000505	0.000728	CcSEcCtD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000505	0.00184	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CCR2—multiple sclerosis	0.000504	0.00183	CbGpPWpGaD
Remifentanil—Somnolence—Methotrexate—multiple sclerosis	0.000504	0.000726	CcSEcCtD
Remifentanil—OPRK1—Signaling Pathways—LINGO1—multiple sclerosis	0.000502	0.00183	CbGpPWpGaD
Remifentanil—Hypersensitivity—Prednisone—multiple sclerosis	0.000499	0.00072	CcSEcCtD
Remifentanil—Dyspepsia—Methotrexate—multiple sclerosis	0.000499	0.000719	CcSEcCtD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000498	0.00181	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.000497	0.00181	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TAGAP—multiple sclerosis	0.000497	0.00181	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—POMC—multiple sclerosis	0.000496	0.00181	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000496	0.0018	CbGpPWpGaD
Remifentanil—Vomiting—Betamethasone—multiple sclerosis	0.000495	0.000714	CcSEcCtD
Remifentanil—Vomiting—Dexamethasone—multiple sclerosis	0.000495	0.000714	CcSEcCtD
Remifentanil—Rash—Betamethasone—multiple sclerosis	0.000491	0.000708	CcSEcCtD
Remifentanil—Rash—Dexamethasone—multiple sclerosis	0.000491	0.000708	CcSEcCtD
Remifentanil—Dermatitis—Betamethasone—multiple sclerosis	0.00049	0.000707	CcSEcCtD
Remifentanil—Dermatitis—Dexamethasone—multiple sclerosis	0.00049	0.000707	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000489	0.000705	CcSEcCtD
Remifentanil—Headache—Betamethasone—multiple sclerosis	0.000488	0.000703	CcSEcCtD
Remifentanil—Headache—Dexamethasone—multiple sclerosis	0.000488	0.000703	CcSEcCtD
Remifentanil—OPRD1—GPCR ligand binding—CCL5—multiple sclerosis	0.000487	0.00177	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.000486	0.00177	CbGpPWpGaD
Remifentanil—Pain—Methotrexate—multiple sclerosis	0.000484	0.000699	CcSEcCtD
Remifentanil—OPRM1—GPCR downstream signaling—GPR65—multiple sclerosis	0.000483	0.00176	CbGpPWpGaD
Remifentanil—Pruritus—Prednisone—multiple sclerosis	0.00048	0.000692	CcSEcCtD
Remifentanil—OPRK1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000475	0.00173	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCR1—multiple sclerosis	0.000475	0.00173	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000473	0.00172	CbGpPWpGaD
Remifentanil—Feeling abnormal—Methotrexate—multiple sclerosis	0.000467	0.000673	CcSEcCtD
Remifentanil—OPRM1—GPCR ligand binding—CNR1—multiple sclerosis	0.000465	0.00169	CbGpPWpGaD
Remifentanil—Diarrhoea—Prednisone—multiple sclerosis	0.000464	0.000669	CcSEcCtD
Remifentanil—OPRM1—Signaling by GPCR—RGS1—multiple sclerosis	0.000463	0.00168	CbGpPWpGaD
Remifentanil—Nausea—Dexamethasone—multiple sclerosis	0.000462	0.000667	CcSEcCtD
Remifentanil—Nausea—Betamethasone—multiple sclerosis	0.000462	0.000667	CcSEcCtD
Remifentanil—Urticaria—Methotrexate—multiple sclerosis	0.00045	0.000649	CcSEcCtD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00045	0.00164	CbGpPWpGaD
Remifentanil—Dizziness—Prednisone—multiple sclerosis	0.000448	0.000646	CcSEcCtD
Remifentanil—Body temperature increased—Methotrexate—multiple sclerosis	0.000448	0.000646	CcSEcCtD
Remifentanil—OPRM1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000442	0.00161	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000442	0.00161	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00044	0.0016	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—GPR65—multiple sclerosis	0.000439	0.0016	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CCR5—multiple sclerosis	0.000438	0.00159	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TAGAP—multiple sclerosis	0.000435	0.00158	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—S1PR1—multiple sclerosis	0.000434	0.00158	CbGpPWpGaD
Remifentanil—Vomiting—Prednisone—multiple sclerosis	0.000431	0.000622	CcSEcCtD
Remifentanil—Rash—Prednisone—multiple sclerosis	0.000427	0.000616	CcSEcCtD
Remifentanil—Dermatitis—Prednisone—multiple sclerosis	0.000427	0.000616	CcSEcCtD
Remifentanil—OPRK1—GPCR ligand binding—CCL5—multiple sclerosis	0.000427	0.00155	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000427	0.00155	CbGpPWpGaD
Remifentanil—Headache—Prednisone—multiple sclerosis	0.000425	0.000612	CcSEcCtD
Remifentanil—OPRM1—Signaling Pathways—LINGO1—multiple sclerosis	0.000424	0.00154	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GPC5—multiple sclerosis	0.000422	0.00154	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—POMC—multiple sclerosis	0.000419	0.00153	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000419	0.00152	CbGpPWpGaD
Remifentanil—Hypersensitivity—Methotrexate—multiple sclerosis	0.000417	0.000602	CcSEcCtD
Remifentanil—OPRD1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000409	0.00149	CbGpPWpGaD
Remifentanil—Nausea—Prednisone—multiple sclerosis	0.000403	0.000581	CcSEcCtD
Remifentanil—OPRM1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000401	0.00146	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCR1—multiple sclerosis	0.000401	0.00146	CbGpPWpGaD
Remifentanil—Pruritus—Methotrexate—multiple sclerosis	0.000401	0.000578	CcSEcCtD
Remifentanil—OPRD1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000395	0.00144	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000394	0.00144	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—IL6—multiple sclerosis	0.000393	0.00143	CbGpPWpGaD
Remifentanil—Diarrhoea—Methotrexate—multiple sclerosis	0.000388	0.000559	CcSEcCtD
Remifentanil—OPRD1—Signaling by GPCR—CCL3—multiple sclerosis	0.000386	0.0014	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000386	0.0014	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000384	0.0014	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CCR5—multiple sclerosis	0.000384	0.0014	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—S1PR1—multiple sclerosis	0.000381	0.00138	CbGpPWpGaD
Remifentanil—Dizziness—Methotrexate—multiple sclerosis	0.000375	0.00054	CcSEcCtD
Remifentanil—OPRD1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000372	0.00135	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GPC5—multiple sclerosis	0.00037	0.00135	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RGS1—multiple sclerosis	0.000369	0.00134	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TAGAP—multiple sclerosis	0.000368	0.00134	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CCL5—multiple sclerosis	0.000361	0.00131	CbGpPWpGaD
Remifentanil—Vomiting—Methotrexate—multiple sclerosis	0.00036	0.000519	CcSEcCtD
Remifentanil—OPRD1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000359	0.00131	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000359	0.00131	CbGpPWpGaD
Remifentanil—Rash—Methotrexate—multiple sclerosis	0.000357	0.000515	CcSEcCtD
Remifentanil—Dermatitis—Methotrexate—multiple sclerosis	0.000357	0.000515	CcSEcCtD
Remifentanil—Headache—Methotrexate—multiple sclerosis	0.000355	0.000512	CcSEcCtD
Remifentanil—OPRD1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000355	0.00129	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GPR65—multiple sclerosis	0.00035	0.00127	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCR2—multiple sclerosis	0.000349	0.00127	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000346	0.00126	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—POMC—multiple sclerosis	0.000343	0.00125	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCL3—multiple sclerosis	0.000338	0.00123	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000337	0.00123	CbGpPWpGaD
Remifentanil—Nausea—Methotrexate—multiple sclerosis	0.000336	0.000485	CcSEcCtD
Remifentanil—OPRD1—GPCR ligand binding—CCL2—multiple sclerosis	0.000335	0.00122	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000333	0.00121	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000326	0.00119	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000326	0.00119	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CCR5—multiple sclerosis	0.000325	0.00118	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RGS1—multiple sclerosis	0.000324	0.00118	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CNR1—multiple sclerosis	0.000322	0.00117	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—S1PR1—multiple sclerosis	0.000322	0.00117	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCL13—multiple sclerosis	0.00032	0.00116	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCR1—multiple sclerosis	0.00032	0.00116	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000319	0.00116	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000315	0.00114	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GPC5—multiple sclerosis	0.000313	0.00114	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000311	0.00113	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GPR65—multiple sclerosis	0.000307	0.00112	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCR2—multiple sclerosis	0.000306	0.00111	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000303	0.0011	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—POMC—multiple sclerosis	0.0003	0.00109	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CCL2—multiple sclerosis	0.000294	0.00107	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000293	0.00107	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CXCL10—multiple sclerosis	0.00029	0.00106	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCL3—multiple sclerosis	0.000286	0.00104	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000285	0.00104	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CNR1—multiple sclerosis	0.000282	0.00103	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCL13—multiple sclerosis	0.000281	0.00102	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCR1—multiple sclerosis	0.000281	0.00102	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00028	0.00102	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000275	0.001	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000275	0.001	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RGS1—multiple sclerosis	0.000274	0.000995	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000266	0.000968	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000263	0.000957	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GPR65—multiple sclerosis	0.000259	0.000943	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCR2—multiple sclerosis	0.000259	0.000941	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000254	0.000925	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—POMC—multiple sclerosis	0.000254	0.000924	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCL5—multiple sclerosis	0.00025	0.000908	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CCL2—multiple sclerosis	0.000248	0.000904	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000248	0.000901	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000244	0.000888	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000241	0.000877	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CNR1—multiple sclerosis	0.000239	0.000869	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCR1—multiple sclerosis	0.000237	0.000863	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCL13—multiple sclerosis	0.000237	0.000863	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000237	0.000861	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCL3—multiple sclerosis	0.000228	0.00083	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCR5—multiple sclerosis	0.000225	0.000818	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000222	0.000807	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PTGER4—multiple sclerosis	0.000219	0.000799	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCL5—multiple sclerosis	0.000219	0.000797	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000217	0.00079	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PGR—multiple sclerosis	0.000216	0.000786	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000215	0.000782	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000214	0.000779	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCR3—multiple sclerosis	0.000212	0.000771	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CD28—multiple sclerosis	0.00021	0.000764	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCR2—multiple sclerosis	0.000206	0.00075	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000204	0.000741	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCL3—multiple sclerosis	0.0002	0.000727	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCR5—multiple sclerosis	0.000197	0.000718	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000194	0.000707	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—POMC—multiple sclerosis	0.000194	0.000704	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PTGER4—multiple sclerosis	0.000192	0.0007	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CNR1—multiple sclerosis	0.00019	0.000692	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PGR—multiple sclerosis	0.00019	0.00069	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCR3—multiple sclerosis	0.000186	0.000676	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCL5—multiple sclerosis	0.000185	0.000673	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CD28—multiple sclerosis	0.000184	0.00067	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000184	0.000668	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000181	0.000658	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCR2—multiple sclerosis	0.000181	0.000658	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—POMC—multiple sclerosis	0.000176	0.00064	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCL2—multiple sclerosis	0.000172	0.000626	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCL10—multiple sclerosis	0.000171	0.000623	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—POMC—multiple sclerosis	0.00017	0.000618	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL3—multiple sclerosis	0.000169	0.000615	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CNR1—multiple sclerosis	0.000167	0.000607	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCR5—multiple sclerosis	0.000167	0.000607	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000164	0.000598	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PTGER4—multiple sclerosis	0.000163	0.000592	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PGR—multiple sclerosis	0.00016	0.000583	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCR3—multiple sclerosis	0.000157	0.000572	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—TYK2—multiple sclerosis	0.000156	0.000568	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CD28—multiple sclerosis	0.000156	0.000566	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—POMC—multiple sclerosis	0.000154	0.000561	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCR2—multiple sclerosis	0.000153	0.000556	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCL2—multiple sclerosis	0.000151	0.000549	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCL10—multiple sclerosis	0.00015	0.000547	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CD86—multiple sclerosis	0.00015	0.000545	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCL5—multiple sclerosis	0.000147	0.000537	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—POMC—multiple sclerosis	0.000143	0.000522	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—IL2—multiple sclerosis	0.000143	0.000521	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CNR1—multiple sclerosis	0.000141	0.000513	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—TYK2—multiple sclerosis	0.000137	0.000498	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SPP1—multiple sclerosis	0.000137	0.000497	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCR5—multiple sclerosis	0.000133	0.000483	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CD86—multiple sclerosis	0.000131	0.000478	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL2RA—multiple sclerosis	0.000131	0.000476	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—POMC—multiple sclerosis	0.00013	0.000474	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL2—multiple sclerosis	0.00013	0.000473	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCL5—multiple sclerosis	0.000129	0.000471	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCL2—multiple sclerosis	0.000127	0.000464	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCL10—multiple sclerosis	0.000127	0.000462	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—IL2—multiple sclerosis	0.000125	0.000457	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APOE—multiple sclerosis	0.000121	0.00044	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SPP1—multiple sclerosis	0.00012	0.000436	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCR5—multiple sclerosis	0.000117	0.000424	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—TYK2—multiple sclerosis	0.000116	0.000421	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL2RA—multiple sclerosis	0.000115	0.000418	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL2—multiple sclerosis	0.000114	0.000415	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CD86—multiple sclerosis	0.000111	0.000404	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL5—multiple sclerosis	0.000109	0.000398	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CD80—multiple sclerosis	0.000109	0.000398	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—IL2—multiple sclerosis	0.000106	0.000386	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APOE—multiple sclerosis	0.000106	0.000386	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—POMC—multiple sclerosis	0.000104	0.000378	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCL2—multiple sclerosis	0.000102	0.00037	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SPP1—multiple sclerosis	0.000101	0.000368	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—MAPK1—multiple sclerosis	9.94e-05	0.000362	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCR5—multiple sclerosis	9.85e-05	0.000358	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL2RA—multiple sclerosis	9.71e-05	0.000353	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL2—multiple sclerosis	9.63e-05	0.00035	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CD80—multiple sclerosis	9.58e-05	0.000349	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TYK2—multiple sclerosis	9.23e-05	0.000336	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—POMC—multiple sclerosis	9.11e-05	0.000331	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOE—multiple sclerosis	8.96e-05	0.000326	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCL2—multiple sclerosis	8.91e-05	0.000324	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—MAPK1—multiple sclerosis	8.72e-05	0.000317	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CD80—multiple sclerosis	8.1e-05	0.000295	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TYK2—multiple sclerosis	8.09e-05	0.000294	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—POMC—multiple sclerosis	7.7e-05	0.00028	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL2—multiple sclerosis	7.68e-05	0.000279	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL6—multiple sclerosis	7.64e-05	0.000278	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL2—multiple sclerosis	7.53e-05	0.000274	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—MAPK1—multiple sclerosis	7.37e-05	0.000268	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MMP9—multiple sclerosis	7.27e-05	0.000264	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TYK2—multiple sclerosis	6.84e-05	0.000249	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL2—multiple sclerosis	6.73e-05	0.000245	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL6—multiple sclerosis	6.7e-05	0.000244	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—STAT3—multiple sclerosis	6.46e-05	0.000235	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MMP9—multiple sclerosis	6.37e-05	0.000232	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MYC—multiple sclerosis	6e-05	0.000218	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TGFB1—multiple sclerosis	5.99e-05	0.000218	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAPK1—multiple sclerosis	5.87e-05	0.000214	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL2—multiple sclerosis	5.69e-05	0.000207	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—STAT3—multiple sclerosis	5.67e-05	0.000206	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6—multiple sclerosis	5.66e-05	0.000206	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MMP9—multiple sclerosis	5.38e-05	0.000196	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MYC—multiple sclerosis	5.26e-05	0.000192	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TGFB1—multiple sclerosis	5.25e-05	0.000191	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAPK1—multiple sclerosis	5.15e-05	0.000187	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—STAT3—multiple sclerosis	4.79e-05	0.000174	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6—multiple sclerosis	4.51e-05	0.000164	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MYC—multiple sclerosis	4.45e-05	0.000162	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TGFB1—multiple sclerosis	4.44e-05	0.000161	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAPK1—multiple sclerosis	4.35e-05	0.000158	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6—multiple sclerosis	3.96e-05	0.000144	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6—multiple sclerosis	3.34e-05	0.000122	CbGpPWpGaD
